Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy

ConclusionsResponse to repeated131I-mIBG treatment can be a strong predictor of prognosis after initial131I-mIBG therapy for refractory PPGL. Repeated131I-mIBG therapy may be a good option for controlling refractory PPGL.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research